Sage Capital is a private equity firm based in St. Louis, Missouri, that provides long-term capital and strategic value to small and lower-middle market companies in North America. Founded in 2004, it concentrates on mezzanine, later-stage, buyouts, growth capital, and recapitalizations, using equity and equity-like instruments. The firm invests across industries with a focus on value-added manufacturers, service businesses, distributors, branded consumer products, and professional services, while avoiding startups and sectors such as commodity processing, construction services, trucking, real estate, and gaming. Sage Capital typically commits between $2 million and $10 million per company, targeting enterprises valued $5 million to $50 million and EBITDA of $2 million to $7 million, though larger deals are possible through co-investments. The firm pursues both majority and minority positions and seeks board seats in portfolio companies. Geographically, it concentrates on the Midwest, Great Lakes, Mid-South, and Central Southern United States, but evaluates opportunities across North America.
Livers Bronze Co. is a commercial railing design and manufacturing company that specializes in creating architectural railing systems for various commercial facilities. The company offers a diverse range of styles and finishes, utilizing an array of materials such as stainless steel, aluminum, bronze, glass, hardwood, and metal cable. In addition to manufacturing, Livers Bronze also provides installation services, ensuring that their products meet the specific aesthetic and functional needs of their clients. With a focus on quality and craftsmanship, Livers Bronze Co. has established itself as a key player in the railing industry.
Shenzhen Uni-medica Technology
Series A in 2015
Shenzhen Uni-medica Technology Co., Ltd specializes in the development, production, and distribution of high-end in vitro diagnostic reagents and instruments. The company focuses on providing integrated diagnostic solutions that cater to various clinical needs. With a commitment to innovation and quality, Shenzhen Uni-medica Technology Co., Ltd has achieved national high-tech enterprise status. The product range includes rapid extraction kits with a processing time of 10 minutes, ensuring efficiency in diagnostic procedures. The company serves a global market, including regions such as Africa, Americas, Asia, Europe, and the Middle East. It holds significant certifications such as EC REP and ISO 9001, underscoring its adherence to international standards in product quality and management systems.
Bontai Biotechnology
Series A in 2015
Bontai Biotechnology focuses on the production and sales of biosynthetic technologies and products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.